IHAM
Integral Health Asset Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-700,000
| Closed | -$553K | – | 83 |
|
|
2025
Q1 | $553K | Buy |
700,000
+100,000
| +17% | +$79K | 0.06% | 76 |
|
|
2024
Q4 | $990K | Sell |
600,000
-375,000
| -38% | -$619K | 0.08% | 80 |
|
|
2024
Q3 | $3.41M | Buy |
975,000
+125,000
| +15% | +$438K | 0.38% | 51 |
|
|
2024
Q2 | $2.79M | Buy |
850,000
+650,000
| +325% | +$2.13M | 0.26% | 65 |
|
|
2024
Q1 | $1.47M | Sell |
200,000
-700,000
| -78% | -$5.14M | 0.14% | 76 |
|
|
2023
Q4 | $3.37M | Buy |
+900,000
| New | +$3.37M | 0.46% | 61 |
|
|
2022
Q1 | – | Sell |
-130,000
| Closed | -$7.61M | – | 79 |
|
|
2021
Q4 | $7.61M | Buy |
130,000
+35,000
| +37% | +$2.05M | 2.1% | 16 |
|
|
2021
Q3 | $5.63M | Buy |
95,000
+15,000
| +19% | +$889K | 1.62% | 22 |
|
|
2021
Q2 | $6.94M | Buy |
80,000
+40,000
| +100% | +$3.47M | 1.91% | 18 |
|
|
2021
Q1 | $3.3M | Buy |
+40,000
| New | +$3.3M | 0.94% | 41 |
|
|
2020
Q4 | – | Sell |
-85,000
| Closed | -$3.4M | – | 66 |
|
|
2020
Q3 | $3.4M | Buy |
85,000
+15,000
| +21% | +$599K | 1.04% | 32 |
|
|
2020
Q2 | $2.4M | Sell |
70,000
-25,000
| -26% | -$858K | 0.72% | 50 |
|
|
2020
Q1 | $2.11M | Buy |
+95,000
| New | +$2.11M | 0.93% | 39 |
|